Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry sheeba farhat25 April 2026 5:06 PM ISTNew Delhi: Swiss drugmaker Roche's first-quarter sales dropped by 5%, it said on Thursday, citing unfavourable foreign exchange effects that offset...
Lilly's Foundayo Clocks 1,390 Prescriptions in Debut Week as Oral Obesity Drug Race Heats Up sheeba farhat19 April 2026 12:09 PM ISTNew Delhi: Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in its first week of sales, according to analysts who...
AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation sheeba farhat15 April 2026 7:00 PM ISTNew Delhi: Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
Novo Slashes Wegovy Prices Amid Lilly's Mounjaro Surge in South African Market sheeba farhat26 March 2026 11:24 PM ISTJohannesburg: Novo Nordisk is cutting South African prices of its weight-loss drug Wegovy for a second time since it launched in August, local...
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management sheeba farhat8 March 2026 11:30 AM ISTShanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...
Patients regain weight rapidly after stopping weight loss drugs-but still keep off quarter of weight lost, states study Dr. Kamal Kant Kohli5 March 2026 8:45 PM ISTA year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight-but beyond this, their...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
Novo Nordisk to Invest USD 506 Million to Expand Oral GLP-1 Drug Manufacturing in Ireland sheeba farhat3 March 2026 8:46 PM ISTNew Delhi: Novo Nordisk said on Monday it will invest 432 million euros (USD 506.43 million) to expand its manufacturing facility in Athlone,...
7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
USFDA Flags Novo Nordisk's Wegovy Advertisement as False, Seeks Immediate Action sheeba farhat11 Feb 2026 8:19 PM ISTUSFDA said the television spot misleadingly suggests that Wegovy in its pill form offers an advancement or improvement over other weight-loss drugs...
